The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications

被引：133
|
作者：
Wen, Patrick Y. [1 ,2 ]
Packer, Roger J. [3 ,4 ,5 ]
机构：
[1] Brigham & Womans Hosp, Dana Farber Canc Inst, Ctr Neurooncol, Div Neurooncol,Dept Neurol, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Childrens Natl Hosp, Ctr Neurosci & Behav Med, Brain Tumor Inst, Gilbert Family Neurofibromatosis Inst, Washington, DC USA
[4] George Washington Univ, Dept Neurol, Washington, DC USA
[5] George Washington Univ, Dept Pediat, Washington, DC 20052 USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷 / 08期
关键词：
D O I：
10.1093/neuonc/noab120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1215 / 1217
页数：3
相关论文
共 50 条
  • [21] The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles
    Takashi Komori
    [J]. Brain Tumor Pathology, 2022, 39 : 47 - 50
  • [22] The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles
    Komori, Takashi
    [J]. BRAIN TUMOR PATHOLOGY, 2022, 39 (02) : 47 - 50
  • [23] 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist
    McNamara, Cillian
    Mankad, Kshitij
    Thust, Stefanie
    Dixon, Luke
    Limback-Stanic, Clara
    D'Arco, Felice
    Jacques, Thomas S.
    Lobel, Ulrike
    [J]. NEURORADIOLOGY, 2022, 64 (10) : 1919 - 1950
  • [24] 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist
    Cillian McNamara
    Kshitij Mankad
    Stefanie Thust
    Luke Dixon
    Clara Limback-Stanic
    Felice D’Arco
    Thomas S. Jacques
    Ulrike Löbel
    [J]. Neuroradiology, 2022, 64 : 1919 - 1950
  • [25] Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system
    Gritsch, Simon
    Batchelor, Tracy T.
    Gonzalez Castro, L. Nicolas
    [J]. CANCER, 2022, 128 (01) : 47 - 58
  • [26] Clinical outcomes of solitary fibrous tumors and hemangiopericytomas and risk factors related to recurrence and survival based on the 2021 WHO classification of central nervous system tumors
    Wu, Yingxi
    Zhao, Tianzhi
    Cai, Yaning
    Zheng, Min
    Zhang, Yunze
    Qu, Yan
    Cai, Qing
    [J]. JOURNAL OF NEUROSURGERY, 2024, 140 (01) : 69 - 79
  • [27] The WHO classification of tumors of the nervous system
    Kleihues, P
    Louis, DN
    Scheithauer, BW
    Rorke, LB
    Reifenberger, G
    Burger, PC
    Cavenee, WK
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (03): : 215 - 225
  • [28] Development of the WHO Classification of Tumors of the Central Nervous System: A Historical Perspective
    Scheithauer, Bernd W.
    [J]. BRAIN PATHOLOGY, 2009, 19 (04) : 551 - 564
  • [29] Implementation of the fifth edition of the WHO classification of tumors of the central nervous system and its implications in a Belgian cohort
    Ahmed, M.
    Sieben, A.
    Verbraeken, B.
    Menovsky, T.
    Rasschaert, M.
    Meijnders, P.
    Cras, P.
    van Kempen, L. C.
    Lammens, M.
    [J]. BRAIN PATHOLOGY, 2023, 33
  • [30] Neuropathology of pediatric brain tumors: Implications of the 5th edition of the WHO classification of central nervous system tumors
    Reyes Medina B.
    Wrede A.
    Schulz-Schaeffer W.J.
    [J]. Die Radiologie, 2023, 63 (8) : 577 - 582
12345